Albuterol-budesonide rescue reduces progression from asthma deterioration to severe exacerbation

Affiliations

• ¹ Capital Allergy & Respiratory Disease Center, Sacramento, Calif.
• ² Department of Respiratory Medicine, University of Ferrara Medical School, Ferrara, Italy.
• ³ Medical Research Institute of New Zealand, Wellington, New Zealand; Capital and Coast District Health Board, Wellington, New Zealand; Victoria University Wellington, Wellington, New Zealand.
• ⁴ Brigham & Women's Hospital, Harvard Medical School, Boston, Mass.
• ⁵ Rutgers Institute for Translational Medicine and Science, Child Health Institute of New Jersey, Rutgers, the State University of New Jersey, New Brunswick, NJ.
• ⁶ Avillion US Inc., Northbrook, Ill.
• ⁷ BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
• ⁸ Late Respiratory and Immunology Biometrics, AstraZeneca, Gaithersburg, Md.
• ⁹ BioPharmaceuticals, US Medical, AstraZeneca, Wilmington, Del. Electronic address: ileen.gilbert@astrazeneca.com.
• ¹⁰ BioPharmaceuticals, US Medical, AstraZeneca, Wilmington, Del.
• ¹¹ BioPharmaceuticals R&D, AstraZeneca, Durham, NC.